Patent expiry and costs for anti-cancer medicines for clinical use: expiry and costs anti-cancer medicines

Brian Godman, Claudia Wild, Alan Haycox

Research output: Contribution to journalEditorial

57 Downloads (Pure)

Abstract

Drs Brian Godman, Claudia Wild and Alan Haycox review the paper by Venkatesan et al on the patent expiry of (non-) tyrosine kinase inhibitors.
Original languageEnglish
Pages (from-to)1-3
Number of pages3
JournalGenerics and Biosimilars Initiative journal
Publication statusAccepted/In press - 17 Mar 2017

Keywords

  • anti cancer medicines
  • medicine patents
  • tyrosine kinase inhibitors

Fingerprint Dive into the research topics of 'Patent expiry and costs for anti-cancer medicines for clinical use: expiry and costs anti-cancer medicines'. Together they form a unique fingerprint.

Cite this